Answers are grounded in this paper and cite their sources.
Diabetic retinopathy (DR) is a complication of diabetes, high blood sugar levels that damage the retina.If left untreated and undiagnosed, it can lead to blindness.DR progress has been reported to be reduced by flavonoids with antioxidant potential.Flavonols like myricetin, which occur naturally, have antioxidant properties.The present work summarises the development of thermoresponsive in situ gelling nanoemulsion containing myricetin providing sustained release and prolonged therapeutic effect for the treatment of diabetic retinopathy.Hydroxypropyl methylcellulose (HPMC) was used as a thermoresponsive gelling agent.Optimized nanoemulgel provided sustained release of myricetin with satisfactory rheological properties and pharmaceutical properties.In conclusion, the nanoemulsion formulations containing in situ gelling thermoresponsive polymer could serve as a promising drug delivery system providing superior therapeutic efficacy and better patient compliance for the treatment of DR.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: